相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1
Tak Yung Man et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Giovanni Musso et al.
ANNALS OF MEDICINE (2011)
Animal models of nonalcoholic fatty liver disease
Lionel Hebbard et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Fatty liver and lipotoxicity
Michael Trauner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Recent advances in nonalcoholic fatty liver disease
Onpan Cheung et al.
CURRENT OPINION IN GASTROENTEROLOGY (2010)
Insulin Resistance in Nonalcoholic Fatty Liver Disease
E. Bugianesi et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
11 beta-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
Stuart A. Morgan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
The Surgical Treatment of Metabolic Disease and Morbid Obesity
Mark A. Fontana et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2010)
Fatty liver disease: the hepatic manifestation of metabolic syndrome
Amalia Gastaldelli
HYPERTENSION RESEARCH (2010)
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Laura L. Gathercole et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease
Nicholas Michael Morton
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
The metabolic syndrome
Robert H. Eckel et al.
LANCET (2010)
Non-alcoholic fatty liver disease from pathogenesis to management: an update
G. Musso et al.
OBESITY REVIEWS (2010)
Overexpression of 11 beta-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients
Rene Baudrand et al.
OBESITY SURGERY (2010)
Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease
Ariel E. Feldstein
SEMINARS IN LIVER DISEASE (2010)
11β-hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension
Carmen Campino et al.
ENDOCRINE (2010)
Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis
Sarah Konopelska et al.
CLINICAL ENDOCRINOLOGY (2009)
Cortisol Release From Adipose Tissue by 11 beta-Hydroxysteroid Dehydrogenase Type 1 in Humans
Roland H. Stimson et al.
DIABETES (2009)
Liver Is the Site of Splanchnic Cortisol Production in Obese Nondiabetic Humans
Rita Basu et al.
DIABETES (2009)
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Panagiotis Anagnostis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
11β-Hydroxysteroid Dehydrogenase Type 1 is Overexpressed in Subcutaneous Adipose Tissue of Morbidly Obese Patients
Rodrigo Munoz et al.
OBESITY SURGERY (2009)
Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease
Mousumi Bose et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
The glucocorticoid receptor controls hepatic dyslipidemia through Hes1
Ulrike Lemke et al.
CELL METABOLISM (2008)
Visceral fat: A key mediator of steatohepatitis in metabolic liver disease
David van der Poorten et al.
HEPATOLOGY (2008)
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
David P. Macfarlane et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Nonalcoholic Fatty Liver Disease: Hepatic Manifestation of Obesity and the Metabolic Syndrome
Hima Boppidi
POSTGRADUATE MEDICINE (2008)
Type 2 diabetes and metabolic syndrome are associated with increased expression of 11β-hydroxysteroid dehydrogenase 1 in obese subjects
L. Alberti et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Cortisol - cause and cure for metabolic syndrome?
B. R. Walker
DIABETIC MEDICINE (2006)
Review: The role of insulin resistance in nonalcoholic fatty liver disease
Kristina M. Utzschneider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Adipose tissue 11β-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome
Barbara Mariniello et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Portal and peripheral cortisol in obese humans
W Aldhahi et al.
DIABETOLOGIA (2004)
Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone
VW Dolinsky et al.
BIOCHEMICAL JOURNAL (2004)
Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase
AG Atanasov et al.
FEBS LETTERS (2004)
11β-hydroxysteroid dehydrogenase type 1:: A tissue-specific regulator of glucocorticoid response
JW Tomlinson et al.
ENDOCRINE REVIEWS (2004)
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati et al.
ANNALS OF INTERNAL MEDICINE (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Non-alcoholic fatty liver disease
P Angulo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
E Bonora et al.
DIABETES CARE (2000)
分享论文
